Source Post
Eli Lilly Stock Investors Should Buy or Sell? | #llystock #elililly #trading #stockmarket #crypto
Aug 12, 2025
The creator remains highly bullish on Eli Lilly (LLY), citing strong revenue growth driven by Zepbound and Mounjaro, increased full-year guidance, and advancements in their pipeline. Despite acknowledging R&D and marketing expenses, the creator believes the stock is undervalued and has a lower risk profile than the broader market.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.